The U.S. FDA has approved our therapy for certain people with pre-treated HR+/HER2- metastatic breast cancer.
Read more.

Social Media Guidelines

We’re glad that you have stopped by this page, and we welcome your interaction with Gilead on social media. Given that we operate in a regulated environment, we would like to share ground rules when engaging with us on social media. 

Gilead Sciences, Inc. (“Gilead,” “We” or “Our”) is a research-based biopharmaceutical company that discovers, develops and delivers innovative therapeutics for people with life-threatening diseases. Gilead uses social media to share stories about our innovation and culture and to spotlight the work of our many partners. Content from Gilead is provided for informational purposes only. We look forward to engaging with you! 


How to Engage with Us

We have a responsibility to manage our social media accounts appropriately in line with the regulatory environment in which we operate. We observe the posting guidelines and terms of use of all the social media platforms on which Gilead has accounts and ask that you observe them too, in addition to the following terms. Should you reply to or mention Gilead, please:

  • Be respectful. Do not use foul language, include explicit material or disparage others in your comments or posts.
  • Stay on topic. Ensure your message relates to Gilead or the communities it serves.
  • Protect your privacy. Do not share confidential or identifying information on Gilead’s public pages.

Gilead reserves all rights relating to our social media accounts and may in its sole discretion add, remove, or modify any content or material posted on the account, discontinue the account, accept or reject those who may wish to follow the account, and respond to any questions or comments addressed to the account.


What We Post: Endorsement and Third-Party Websites

Social media accounts that Gilead follows or engages with or is followed by do not indicate an endorsement by Gilead of the account owner or their products and services.

Any content, views, opinions, and/or engagements uploaded or expressed by any person other than Gilead are solely the views, opinions and responsibility of the person uploading or expressing them and do not necessarily reflect the opinions of Gilead. Gilead is not responsible for content that third parties transmit via social media.

Gilead may provide links or references to other websites as part of its social messaging. However, Gilead claims no responsibility for the accuracy or content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this platform.

Gilead is not affiliated with any social media platforms or related sites. Gilead is not responsible for the security, privacy, or other policies or practices on social media or on any of the third-party websites that Gilead may link to or reference through social media. Any personal information provided to these third-party websites shall be governed by the privacy policies of these third-party websites. You should carefully review the security, privacy, and other policies and practices of each social media platform and linked or referenced third-party websites.


What You Should Know: Health and Safety

 

Medicines and Medical Treatment
As a biopharmaceutical company, we are unable to comment on or advise individual patients about their medical condition and treatment. It is very important that patients are advised by a health professional who knows their medical and treatment history.    

Product Information
Gilead does not view social media platforms as forums for product inquiries. For product information, please refer to our medical information website, or call 1-866-MEDI-GSI (1-866-633-4474). If your inquiry is of an urgent nature, please call 1-800-GILEAD-5 to speak with the appropriate Gilead representative.  

Suspected Adverse Events
Patient safety is of utmost importance to Gilead and we take all information related to our medicines seriously. We have a legal and ethical duty to follow up on any reports of adverse events associated with our medicines, which in turn assists us with the monitoring of their safety profiles. Healthcare professionals and patients may request specific product information or report an adverse event or product complaint with one of Gilead's marketed and investigational products from our Medical Information department.  

For more information, please call 1-800-GILEAD-5 (1-800-445-3235), option 2.

You may also report any adverse event directly to your healthcare provider or to the U.S. Food and Drug Administration (FDA) by calling 1-800-FDA-1088 or visiting the FDA website.


Additional Disclaimers

The Gilead logo and images are trademarks of Gilead, and Gilead owns all rights therein.

Any information expressed by Gilead is subject to risk factors and information on forward-looking statements contained in our filings with the Securities and Exchange Commission and available online here.